PELAIA, GIROLAMO
 Distribuzione geografica
Continente #
NA - Nord America 3.714
AS - Asia 1.895
EU - Europa 1.386
SA - Sud America 319
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 7.357
Nazione #
US - Stati Uniti d'America 3.570
SG - Singapore 1.065
IT - Italia 666
CN - Cina 541
BR - Brasile 260
DE - Germania 183
GB - Regno Unito 154
SE - Svezia 142
CA - Canada 116
VN - Vietnam 65
FI - Finlandia 63
HK - Hong Kong 57
IN - India 40
NL - Olanda 27
BD - Bangladesh 24
ES - Italia 23
MX - Messico 22
AR - Argentina 19
FR - Francia 19
PL - Polonia 19
RU - Federazione Russa 18
TR - Turchia 17
JP - Giappone 14
CZ - Repubblica Ceca 13
IQ - Iraq 12
ZA - Sudafrica 12
ID - Indonesia 11
EC - Ecuador 9
IE - Irlanda 9
UA - Ucraina 9
PE - Perù 8
PY - Paraguay 8
LT - Lituania 7
PK - Pakistan 7
RO - Romania 7
AU - Australia 6
CL - Cile 6
AT - Austria 5
EU - Europa 5
IL - Israele 5
SA - Arabia Saudita 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
IR - Iran 4
JO - Giordania 4
KE - Kenya 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CH - Svizzera 3
CO - Colombia 3
EG - Egitto 3
PT - Portogallo 3
TN - Tunisia 3
VE - Venezuela 3
BN - Brunei Darussalam 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
MY - Malesia 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AO - Angola 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
KR - Corea 1
LV - Lettonia 1
MA - Marocco 1
MR - Mauritania 1
NC - Nuova Caledonia 1
NE - Niger 1
OM - Oman 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 7.357
Città #
Chandler 574
Singapore 470
Santa Clara 304
Hefei 288
Dallas 266
Milan 243
Lawrence 227
Princeton 227
Wilmington 144
Ashburn 131
Munich 120
Chicago 114
London 114
Ottawa 91
Des Moines 71
Catanzaro 67
Hong Kong 55
Turku 46
Boardman 45
São Paulo 32
Los Angeles 30
Shanghai 30
New York 25
Rome 24
San Francisco 22
Naples 21
Ho Chi Minh City 20
Atlanta 19
Brooklyn 19
Guangzhou 19
Redwood City 19
Warsaw 19
Hanoi 18
Norwalk 18
The Dalles 18
Seattle 17
Beijing 16
Hanover 16
Palermo 16
San Nicola Manfredi 16
Redmond 15
Troina 15
Boston 14
Helsinki 14
Olomouc 13
Columbus 12
Phoenix 12
Ankara 11
Mexico City 11
Tokyo 10
Florence 9
Pune 9
Shenzhen 9
Council Bluffs 8
Dublin 8
Johannesburg 8
Rio de Janeiro 8
Amsterdam 7
Augusta 7
Dhaka 7
Falls Church 7
Lima 7
Rogliano 7
Stockholm 7
Toronto 7
Wuhan 7
Assago 6
Bologna 6
Ferrara 6
Mountain View 6
Padova 6
Paris 6
Quito 6
Salerno 6
Wuxi 6
Baghdad 5
Belo Horizonte 5
Campinas 5
Charlotte 5
Jiaxing 5
Messina 5
Montreal 5
Quanzhou 5
Shenyang 5
Turin 5
Ann Arbor 4
Aversa 4
Chennai 4
Cherasco 4
Crotone 4
Curitiba 4
Da Nang 4
Denver 4
Horia 4
Houston 4
Lamezia Terme 4
Manchester 4
Nairobi 4
New Delhi 4
Providence 4
Totale 4.444
Nome #
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells 90
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 70
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 70
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 68
Application of proteomics and peptidomics to COPD 62
High-flow nasal oxygen therapy in intensive care and anaesthesia 61
Ruolo dei calcio-antagonisti nella prevenzione e nel trattamento dell’asma bronchiale 61
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 57
Asthma and COPD proteomics: Current approaches and future directions 56
High-flow nasal cannula oxygen therapy for outpatients undergoing flexible bronchoscopy: a randomised controlled trial 56
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 54
The sodium-phosphate co-transporter SLC34A2, and pulmonary alveolar microlithiasis: presentation of an inbred family and a novel truncating mutation in exon 3 54
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 53
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 51
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe Eosinophilic Asthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission 50
A case of Hughes-Stovin sindrome associated with Budd-Chiari sindrome 49
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 49
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 47
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy 46
A single-blind comparative study of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 46
Adverse drug reactions to antibiotics observed in two pulmonology divisions of Catanzaro, Italy: A six-year retrospective study 46
A case of alveolar proteinosis associated with pulmonary nocardiosis 45
Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose 45
Alpha-interferon and its effects on signal transduction pathways 44
A case of Hughes-Stovin syndrome associated with Budd-Chiari syndrome 43
Benralizumab:from the basic mechanism of action to the potential use in the biological therapy of severe eosinophilic asthma 42
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 42
Adverse drug reactions in hospitalized patients following antibiotics administration 42
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 42
Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma 42
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 42
Is the mitochondrial benzodiazepine receptor involved in the control of airway smooth muscle tone? 41
Airways smooth muscle response to biological stimuli 41
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 41
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 41
Kartagener's syndrome in a woman with a normal ciliary structure and an intracranial meningioma 40
Adverse drug reactions in hospitalized patients following NSAIDs administration 40
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 40
Anticolinergici 40
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 40
The severe asthma network in Italy: findings and perspectives 39
Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments 39
Clinical relevance of understanding mitogen-activated protein kinases involved in asthma 39
Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence 39
Agonisti beta2-adrenergici 38
A single-blind, partial crossover clinical trial of the effects of inhaled fluticasone propionate and nedocromil sodium on airway hyperresponsiveness to methacholine 38
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 38
Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury 38
Treatment of COPD by dual bronchodilation with co-formulation of indacaterol/glycopyrronium 37
Adverse drug reactions in hospitalized patients following bronchodilators administration 37
Asthma management in a specialist setting: results of an Italian Respiratory Society survey 37
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 37
New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant 37
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 37
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 37
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 36
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 36
Applicazioni della Biologia Molecolare alle Malattie Respiratorie 36
Enfisema polmonare 36
P38 signalling pathway in primary cultures of human bronchial epithelial cells: effects of transforming growth factor-β and pharmacological modulation by budesonide 36
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-indipendent and associated with an increase of CD25+ cells 36
Patogenesi e terapia dell’asma bronchiale: recenti acquisizioni, 36
Effects of transforming growth factor-β and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 36
Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma 36
Role of biologics in severe eosinophilic asthma - focus on reslizumab 35
LEBRIKIZUMAB Anti-interleukin-13 monoclonal antibody, Treatment of asthma 35
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 35
Bronchial asthma induced by an antithyroid drug 34
Omalizumab riduce la frequenza delle riacutizzazioni, l’assunzione orale di corticosteroidi e l’eosinofilia ematica in pazienti atopici con asma cronico severo 34
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 34
Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma 34
Real-Life Clinical and Functional Effects of Fluticasone Furoate/Umeclidinium/Vilanterol-Combined Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease 34
Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases 33
Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells 33
Exhaled nitric oxide during humming: potential clinical tool in sinonasal disease? 33
Dupilumab: a novel treatment for asthma 33
I beta2-adrenergici 33
Oxidative Stress and Respiratory Disease 33
Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma 33
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 33
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 33
Real-Life Effects of Omalizumab on Chronic Rhinosinusitis with Nasal Polyposis 32
Effects of transforming growth factor-beta and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells 32
Valutazione comparativa dell’effetto protettivo del broxaterolo e del salbutamolo nei confronti del broncospasmo indotto da nebbia ultrasonica di acqua distillata 32
A rare case of infection of the lower respiratory tract caused by Bordetella bronchiseptica 32
Emerging biological treatments for asthma 31
New perspectives in asthma treatment 31
VIP: a new promising marker for AECOPD or a fashionable marker soon forgotten? 31
Effects of non-bronchoconstrictive doses of inhaled propranolol on airway responsiveness to methacholine 31
Azioni degli steroidi sul rilascio delle citochine 31
Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma 31
Adverse drug reaction in two pneumology units of Catanzaro 31
Nitric oxide in upper airways inflammatory diseases 30
Respiratory infections and asthma 30
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness 30
STRUCTURE OF THE RAT GENE ENCODING THE MITOCHONDRIAL BENZODIAZEPINE RECEPTOR 30
Possibility of identification and expression modality of bronchogenic carcinoma 30
Use of narrative medicine to identify key factors for effective doctor-patient relationships in severe asthma 30
null 30
As-needed anti-inflammatory reliever therapy for asthma management: evidence and practical considerations 30
Totale 4.037
Categoria #
all - tutte 104.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021214 0 0 7 33 24 13 7 6 86 25 6 7
2021/2022584 4 5 19 111 46 18 31 141 53 57 89 10
2022/20231.692 465 65 66 127 182 169 16 116 276 78 110 22
2023/2024686 143 90 59 37 36 169 14 24 8 27 24 55
2024/20252.733 412 137 97 105 196 345 93 75 351 145 284 493
2025/20261.443 325 755 363 0 0 0 0 0 0 0 0 0
Totale 7.597